Papers - KATO, Masashi
-
A redox-linked novel pathway for arsenic-mediated RET tyrosine kinase activation
Kato M, Takeda K, Hossain K, Thang D. Nguyen, Kaneko Y, Kumasaka M, Yamanoshita O, Uemura N, Takahashi M, Ohgami N, Kawamoto Y
J Cell Biochem Vol. 110 page： 399-407 2010.5
-
c-RET molecule in malignant melanoma from oncogenic RET-carrying transgenic mice and human cell lines
Ohshima Y, Yajima I, Takeda K, Iida M, Kumasaka M, Matsumoto Y, Kato M
PLoS ONE Vol. 5 ( 4 ) page： e10279 2010.4
-
Ergün S and Schadendorf D: Resistance to anti-angiogenic therapy is directed by vascular phenotype, vessel stabilization and maturation in malignant melanoma.
Helfrich I, Scheffrahn I, Bartling S, Weis J, von Felbert V, Middleton M, Kato M
J Exp Med Vol. 207 ( 3 ) page： 491-503 2010.3
-
Increased CD109 expression levels in human malignant melanoma
Ohshima Y, Yajima I, Kumasaka YM, Yanagishita T, Watanabe D, Takahashi M, Inoue Y, Ihn H, Matsumoto Y, Kato M
J Dermatol Sci Vol. 57 ( 2 ) page： 140-2 2010.2
-
A Novel Mouse Model for de novo melanoma
Kumasaka YM, Yajima I, Hossain K, Iida M, Tsuzuki T, Ohno T, Takahashi M, Yanagisawa M, Kato M
Cancer Res Vol. 70 ( 1 ) page： 24-9 2010.1
-
Toxic Elements in Well Water from Malaysia
Kato M, Ohnuma S, Kato Y, Thang D. Nguyen, Yajima I, Hoque Z. Mohammad, Shekhar U. Hossain
Toxicol Environ Chem Vol. 92 ( 9 ) page： 1609-12 2010
-
1,4-butanediyl-bismethanethiosulfonate (BMTS) induces reactive oxygen species-mediated apoptotic signals independent of stress-activated MAPK cascade in Jurkat cells.
Hossain K, Kawamoto Y, Hamada M, Akhand A, Yanagishita T, Hoque Md. A, Tsuboi H, Kato M, Nakashima I
J Cell Biochem Vol. 108 ( 5 ) page： 1059-65 2009.12
-
Skin Melanoma Development in Ret Transgenic Mice Despite the Depletion of CD25+FoxP3+ Regulatory T-Cells in Lymphoid Organs.
Kimpfler S, Ring S, Falk C, Osen W, Kato M, Mahnke K, Schadendorf D, Umansky V
J Immunol Vol. 183 ( 10 ) page： 6330-7 2009.11
-
Mendelsohn C, Costantini F: Ret-dependent cell rearrangements in the Wolffian duct epithelium initiate ureteric bud morphogenesis.
Chi X, Michos O, Shakya R, Riccio P, Enomoto H, Licht JD, Asai N, Takahashi M, Ohgami N, Kato M
Dev Cell Vol. 17 ( 2 ) page： 199-209 2009.8
-
Activation of p38 MAPK Drives Dendritic Cells to Become Tolerogenic in Ret Transgenic Mice Spontaneously Developing Melanoma.
Zhao F, Falk C, Osen W, Kato M, Schadendorf D, Umansky V
Clin Cancer Res Vol. 15 ( 13 ) page： 4382-90 2009.7
-
Zinc finger protein 28 as a novel melanoma-related molecule.
Yajima I, Kumasaka M, Thang ND, Yanagishita T, Ohgami N, Kallenberg D, Naito Y, Yoshikawa T, Sakashita N, Kato M.
J Dermatol Sci Vol. 55 ( 1 ) page： 68-70 2009.7
-
NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.
Lakshmikanth T, Burke S, Ali TH, Kimpfler S, Ursini F, a Ruggeri L, Capanni M, Umansky V, Paschen A, Sucker A, Pende D, Groh V, Biassoni R, Höglund P, Kato M, Shibuya K, Schadendorf D, Anichini A, Ferrone S, Velardi A, Kärre K, Shibuya A, Carbone E, Colucci F.
J Clin Invest Vol. 119 ( 5 ) page： 1251-63 2009.5
-
Melanoma Specific Memory T Cells Are Functionally Active in Ret Transgenic Mice Without Macroscopical Tumors.
Umansky V, Abschuetz O, Osen W, Ramacher M, Zhao F, Kato M
Cancer Res Vol. 68 ( 22 ) page： 9451-8 2008.11
-
BMP-4 Upregulates Kit Expression in Mouse Melanoblasts prior to the Kit-Dependent Cycle of Melanogenesis.
Kawakami T, Kimura S, Kawa Y, Kato M, Mizoguchi M, Soma Y
J Invest Dermatol Vol. 128 ( 5 ) page： 1220-6 2008.5
-
Distinct role for CD8 T cells toward cutaneous tumors and visceral metastases.
Lengagne R, Graff-Dubois S, Garcette M, Renia L, Kato M, Guillet J, Engelhard HV, Avril M, Abastado J and Prévost-Blondel A
J Immunol Vol. 180 ( 1 ) page： 130-7 2008.1
-
Arsenic enhances matrix metalloproteinase-14 expression in fibroblasts.
Kato M, Hossain K, Iida M, Sato H, Uemura N, Goto Y
J Toxicol Environ Health A Vol. 71 ( 16 ) page： 1053-5 2008
-
Protective Effect of Hyperpigmented Skin on Ultraviolet-Mediated Cutaneous Cancer Development.
Kato M, Ohgami N, Kawamoto Y, Tsuzuki T, Hossain K, Yanagishita T, Ohshima Y, Tsuboi H, Yamanoshita O, Matsumoto Y, Takahashi M, Nakashima I
J Invest Dermatol Vol. 127 ( 5 ) page： 1244-9 2007.5
-
Novel hairless RET-transgenic mouse line with melanocytic nevi and anagen hair follicles.
Kato M, Takeda K, Kawamoto Y, Tsuzuki T, Kato Y, Ohno T, Hossain K, Iftakhar-E-Khuda I, Ohgami N, Isobe K, Takahashi M, Nakashima I
J Invest Dermatol Vol. 126 ( 11 ) page： 2547-50 2006.11
-
A PKC-mediated backup mechanism of the MXXCW motif-linked switch for initiating tyrosine kinase activities.
Takeda K, Kawamoto Y, Okuno Y, Kato M, Takahashi M, Suzuki H, Isobe K, Nakashima I
FEBS Letters Vol. 580 page： 839-43 2006.2
-
5-aminolaevulinic acid photodynamic therapy in a transgenic mouse model of skin melanoma.
Córdoba F, Braathen LR, Weissenberger J, Vallan C, Kato M, Nakashima I, Weis J,
Exp Dermatology Vol. 14 page： 429-37 2005.6